What is OS Therapies's D&A?

OS Therapies (OSTX) reported D&A of $124.94K in Q1 2026.

How has OS Therapies's D&A changed year-over-year?

OS Therapies's D&A increased by 17876.7% year-over-year, from $695 to $124.94K.

What is the long-term trend for OS Therapies's D&A?

Over 2 years (2023 to 2025), OS Therapies's D&A has grown at a 827.6% compound annual growth rate (CAGR), from $4.22K to $363.09K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

OS Therapies OSTX D&A

D&A at other companies

ImmunomeIMNM

$603K-1.3%

Avalo TherapeuticsAVTX

$17K-87.4%

Arcus BiosciencesRCUS

$2M-33.3%

ImmunityBio, Inc.IBRX

$4.38M+14.4%

WHW

Whitehawk Therapeutics, Inc. Common StockWHWK

$1K-98.2%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's D&A?: OS Therapies (OSTX) reported D&A of $124.94K in Q1 2026.
How has OS Therapies's D&A changed year-over-year?: OS Therapies's D&A increased by 17876.7% year-over-year, from $695 to $124.94K.
What is the long-term trend for OS Therapies's D&A?: Over 2 years (2023 to 2025), OS Therapies's D&A has grown at a 827.6% compound annual growth rate (CAGR), from $4.22K to $363.09K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.